Agios ex-CEO joins GV as life sciences investment team's co-head
February 11, 2019 at 12:09 PM EST
After handing over control of one of the Bay State's most promising commercial biotech companies, David Schenkein is joining GV as a the co-head of its life sciences investment branch.